Sichenzia Ross Ference LLP Represents Aegis Capital Corp. in $8.5 Million Underwritten Public Offering of American Depositary Shares of Medigus Ltd.
Press Release – New York, NY – March 2, 2021– Sichenzia Ross Ference LLP today announced that it represented Aegis Capital Corp., as a sole bookrunner in the underwritten public offering of 3,258,438 American Depositary Shares (the “ADSs”) of Medigus Ltd. (NASDAQ: MDGS), a technology company engaged in advanced medical solutions and innovative internet technologies. The ADSs were sold to the public at a price of $2.60 per ADS for gross proceeds of approximately $8.5 million.
This offering was made pursuant to an effective registration statement on Form F-3 (No 333-238162) previously filed with the U.S. Securities and Exchange Commission (the “SEC”) and declared effective by the SEC on May 15, 2020.
The Sichenzia Ross Ference LLP team was led by partners Gregory Sichenzia, Darrin M. Ocasio, and Barrett DiPaolo and associate Terra Melson.
- Sichenzia Ross Ference LLP Represents Cyngn, Inc. in $26.3 Million Initial Public Offering - October 22, 2021
- Sichenzia Ross Ference LLP Represents Parsec Capital Acquisition Corp. in $86.3 Million Initial Public Offering - October 11, 2021
- Sichenzia Ross Ference LLP Joins Biotricity in Ringing Opening Bell at Nasdaq MarketSite - October 7, 2021